Modified adeno-associated viral capsid proteins for ocular gene therapy and methods of use thereof
MYPI2025005929A0Undetermined Publication Date: 2021-07-29GENZYME CORP
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025005929
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-01-29
- Filing Date
- 2021-01-29
- Publication Date
- 2021-07-29
Abstract
Provided herein are modified adeno-associated viral (AAV) capsid proteins, compositions (e.g., rAAV) comprising the capsid proteins, and nucleic acids encoding the capsid proteins. The AAV capsids provided herein confer retinal cell tropism and / or corneal cell tropism, and mediate improved transduction efficiency in clinically relevant ocular cell types such as photoreceptors and / or corneal endothelial cells. Also provided are nucleic acids encoding the capsid proteins, and AAV particles comprising the capsid proteins.
Need to check novelty before this filing date? Find Prior Art
